Stock 300813 ZHEJIANG TAILIN BIOENGINEERING CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

All News Zhejiang Tailin BioEngineering Co.,Ltd

Equities

300813

CNE100003S89

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-14 pm EDT 		5-day change 1st Jan Change
21.99 CNY -8.15% Intraday chart for Zhejiang Tailin BioEngineering Co.,Ltd +17.97% -10.32%
Apr. 23 Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
2023 Zhejiang Tailin Medical Engineering Co., Ltd. announced that it expects to receive CNY 170 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Cash Dividend for 2023
CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Zhejiang Tailin Medical Engineering Co., Ltd. announced that it expects to receive CNY 170 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd
CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Zhejiang Tailin Bioengineering Co.,Ltd Approves Cash Dividend for the Year 2022, Payable on 11 May 2023
CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Zhejiang Tailin Bioengineering Co.,Ltd. Proposes Final Cash Dividend for 2022
CI
Certain A Shares of Zhejiang Tailin BioEngineering Co.,Ltd are subject to a Lock-Up Agreement Ending on 15-JAN-2023.
CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Zhejiang Tailin Medical Engineering Co., Ltd. announced that it has received CNY 40 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd
CI
Zhejiang Tailin Bioengineering Co.,Ltd Approves the Final Cash Dividend for the Year 2021, Payable on May 18, 2022
CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Cash Dividend for the Year of 2021
CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Zhejiang Tailin Life Science Co., Ltd. announced that it expects to receive CNY 40 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd
CI
Zhejiang Tailin Bioengineering Sells $33 Million RMB Convertible Bonds
MT
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
Zhejiang Tailin Bioengineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300813 Stock
  4. News Zhejiang Tailin BioEngineering Co.,Ltd
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW